Media

Our latest news, announcements and multimedia resources

Latest news

February 18, 2025

WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications

February 6, 2025

Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma

February 4, 2025

Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results

January 31, 2025

Merck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults

January 30, 2025

Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis

January 28, 2025

Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization

January 28, 2025

Merck Issues Statement on GARDASIL® Litigation

January 2, 2025

Merck honors the life and legacy of President Jimmy Carter

November 20, 2024

Merck Foundation Heightens Focus on Advancing Equity in Cardiac Care Across the U.S.

September 26, 2024

Merck Provides Update on FDA’s Oncologic Drugs Advisory Committee Meeting Discussion of PD-L1 Expression Levels in Certain Advanced Gastric, Gastroesophageal Junction and Esophageal Cancer Indications

August 22, 2024

FDA’s Oncologic Drugs Advisory Committee to Discuss PD-L1 Expression Thresholds in Certain Advanced Gastric, Gastroesophageal Junction and Esophageal Cancer Indications for Immune Checkpoint Inhibitors in the U.S., Including KEYTRUDA® (pembrolizumab)

August 19, 2024

Merck Reports Strong Momentum in Expanding and Enabling Access to Health Care, Driving Sustainability and Operating Responsibly in 2023/2024 Impact Report

Media resources

Bright light tubes against a silver wall

News releases

Read our latest news releases.

Underside of a staircase

Company statements

Read our latest company statements.

Man reviewing post-it-notes on glass wall

Media library

Access videos, logos, photos and infographics.

Media contacts

Global media relations

+1 908-740-5633

mediarelations@merck.com

Get to know us through our stories

Everything we do, in and out of the laboratory, is based on our deep appreciation for life. Get a glimpse of what it’s like on the inside through our stories.

Scientist reviewing test tubes

We are driven by a single purpose

We use the power of leading-edge science to save and improve lives around the world.

Learn more about our company

Person reviewing product pipeline on their smartphone

Investor relations

Find our latest financials, events & presentations, news, stock information and investor contacts.

Visit investor relations

Two employees in the lobby on their laptops

Company fact sheet

Access company information including stock ticker, official company names, description, and more.

See company fact sheet

Unsubscribe from email alerts